Lv1
90 积分 2026-08-13 加入
Global research landscape of natural medicines for lower urinary tract symptoms: bibliometric and clinical trial analysis
18天前
已完结
CLCC1 governs ER bilayer equilibration to maintain lipid homeostasis
1个月前
已完结
Integrated clinicogenomic analysis reveals the evolution and metastatic tropisms of advanced colorectal cancer
1个月前
已完结
Integrating clinically actionable biomarkers into bladder cancer care - recommendations from the International Bladder Cancer Group
1个月前
已完结
Pulmonary Nodules
1个月前
已完结
Updated Guidance for Author Use of AI in Medical Publication
1个月前
已完结
In vivo tracking of 111In-oxine labeled mesenchymal stem cells following infusion in patients with advanced cirrhosis
1个月前
已完结
Sleuth identifies dozens of studies that used the wrong antibody
1个月前
已完结
Predicting cellular responses to perturbation across diverse contexts with State
1个月前
已完结
Phase III, randomized, double-blind, placebo-controlled study of adjuvant saruparib (AZD5305) in patients with BRCAm localized high-risk prostate cancer who are receiving radiotherapy and androgen deprivation therapy (EvoPAR-Prostate02)
1个月前
已完结
皖公网安备34019202002308
